6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one

C83H92N22O10S4 — CID 159944337

IUPAC6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one
SMILESC=C(c1cc2cnc(Nc3ccc(C4CCCNC4)cc3)nc2n(Cc2nccn2S(=O)(=O)C(C)C)c1=O)C1CC1.CCOc1cc2cnc(Nc3ccc(C4CCN(C)C4)cc3)nc2n(Cc2ccnn2S(C)(=O)=O)c1=O.O=c1c(C2CC2)cc2cnc(Nc3ccc(C4CCNCC4)cc3)nc2n1Cc1cncn1S(=O)(=O)c1nccs1
InChIInChI=1S/C30H35N7O3S.C28H28N8O3S2.C25H29N7O4S/c1-19(2)41(39,40)37-14-13-32-27(37)18-36-28-24(15-26(29(36)38)20(3)21-6-7-21)17-33-30(35-28)34-25-10-8-22(9-11-25)23-5-4-12-31-16-23;37-26-24(20-1-2-20)13-21-14-32-27(33-22-5-3-18(4-6-22)19-7-9-29-10-8-19)34-25(21)35(26)16-23-15-30-17-36(23)41(38,39)28-31-11-12-40-28;1-4-36-22-13-19-14-26-25(28-20-7-5-17(6-8-20)18-10-12-30(2)15-18)29-23(19)31(24(22)33)16-21-9-11-27-32(21)37(3,34)35/h8-11,13-15,17,19,21,23,31H,3-7,12,16,18H2,1-2H3,(H,33,34,35);3-6,11-15,17,19-20,29H,1-2,7-10,16H2,(H,32,33,34);5-9,11,13-14,18H,4,10,12,15-16H2,1-3H3,(H,26,28,29)
InChIKeyOBHJGHOYZNARCW-UHFFFAOYSA-N
MW1686.06 g/mol
LogP10.48
Rot. Bonds25

About 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one

6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one (PubChem CID 159944337) has the molecular formula C83H92N22O10S4 and a molecular weight of 1686.06 g/mol. Its IUPAC name is 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one.

Molecular Properties

Compound Name6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one
PubChem CID159944337
Molecular FormulaC83H92N22O10S4
Molecular Weight1686.06 g/mol
Exact Mass1684.62
IUPAC Name6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one
SMILESC=C(c1cc2cnc(Nc3ccc(C4CCCNC4)cc3)nc2n(Cc2nccn2S(=O)(=O)C(C)C)c1=O)C1CC1.CCOc1cc2cnc(Nc3ccc(C4CCN(C)C4)cc3)nc2n(Cc2ccnn2S(C)(=O)=O)c1=O.O=c1c(C2CC2)cc2cnc(Nc3ccc(C4CCNCC4)cc3)nc2n1Cc1cncn1S(=O)(=O)c1nccs1
InChIInChI=1S/C30H35N7O3S.C28H28N8O3S2.C25H29N7O4S/c1-19(2)41(39,40)37-14-13-32-27(37)18-36-28-24(15-26(29(36)38)20(3)21-6-7-21)17-33-30(35-28)34-25-10-8-22(9-11-25)23-5-4-12-31-16-23;37-26-24(20-1-2-20)13-21-14-32-27(33-22-5-3-18(4-6-22)19-7-9-29-10-8-19)34-25(21)35(26)16-23-15-30-17-36(23)41(38,39)28-31-11-12-40-28;1-4-36-22-13-19-14-26-25(28-20-7-5-17(6-8-20)18-10-12-30(2)15-18)29-23(19)31(24(22)33)16-21-9-11-27-32(21)37(3,34)35/h8-11,13-15,17,19,21,23,31H,3-7,12,16,18H2,1-2H3,(H,33,34,35);3-6,11-15,17,19-20,29H,1-2,7-10,16H2,(H,32,33,34);5-9,11,13-14,18H,4,10,12,15-16H2,1-3H3,(H,26,28,29)
InChIKeyOBHJGHOYZNARCW-UHFFFAOYSA-N
XLogP10.48
TPSA384.73 Ų
H-Bond Donors5
H-Bond Acceptors33
Rotatable Bonds25
Heavy Atoms119
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001686.06
LogP ≤ 510.48
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1033

Analyze 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one?
The IUPAC name of 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one (CID 159944337) is 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one.
What is the SMILES notation for 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one?
The canonical SMILES for 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one is C=C(c1cc2cnc(Nc3ccc(C4CCCNC4)cc3)nc2n(Cc2nccn2S(=O)(=O)C(C)C)c1=O)C1CC1.CCOc1cc2cnc(Nc3ccc(C4CCN(C)C4)cc3)nc2n(Cc2ccnn2S(C)(=O)=O)c1=O.O=c1c(C2CC2)cc2cnc(Nc3ccc(C4CCNCC4)cc3)nc2n1Cc1cncn1S(=O)(=O)c1nccs1.
What is the InChIKey of 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one?
The InChIKey is OBHJGHOYZNARCW-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H35N7O3S.C28H28N8O3S2.C25H29N7O4S/c1-19(2)41(39,40)37-14-13-32-27(37)18-36-28-24(15-26(29(36)38)20(3)21-6-7-21)17-33-30(35-28)34-25-10-8-22(9-11-25)23-5-4-12-31-16-23;37-26-24(20-1-2-20)13-21-14-32-27(33-22-5-3-18(4-6-22)19-7-9-29-10-8-19)34-25(21)35(26)16-23-15-30-17-36(23)41(38,39)28-31-11-12-40-28;1-4-36-22-13-19-14-26-25(28-20-7-5-17(6-8-20)18-10-12-30(2)15-18)29-23(19)31(24(22)33)16-21-9-11-27-32(21)37(3,34)35/h8-11,13-15,17,19,21,23,31H,3-7,12,16,18H2,1-2H3,(H,33,34,35);3-6,11-15,17,19-20,29H,1-2,7-10,16H2,(H,32,33,34);5-9,11,13-14,18H,4,10,12,15-16H2,1-3H3,(H,26,28,29).
What are the key properties of 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one?
6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one has a molecular weight of 1686.06 g/mol, XLogP of 10.48, 25 rotatable bonds, 5 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(1-cyclopropylethenyl)-2-(4-piperidin-3-ylanilino)-8-[(1-propan-2-ylsulfonylimidazol-2-yl)methyl]pyrido[2,3-d]pyrimidin-7-one;6-cyclopropyl-2-(4-piperidin-4-ylanilino)-8-[[3-(1,3-thiazol-2-ylsulfonyl)imidazol-4-yl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-ethoxy-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-[(2-methylsulfonylpyrazol-3-yl)methyl]pyrido[2,3-d]pyrimidin-7-one is sourced from PubChem (CID 159944337), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).